Skip to Main Content

Author Details

Alexander Gusev
The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
2006
75
36
PMIDPaper TitleJournal TitlePublished Year
36939312The lingering effects of Neanderthal introgression on human complex traits.Elife2023
37612286A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
36945630Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain.medRxiv2023
36939312The lingering effects of Neanderthal introgression on human complex traits.Elife2023
36546757Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.Nucleic Acids Res2023
37490908Genotype error due to low-coverage sequencing induces uncertainty in polygenic scoring.Am J Hum Genet2023
37490908Genotype error due to low-coverage sequencing induces uncertainty in polygenic scoring.Am J Hum Genet2023
37612286A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
36945630Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain.medRxiv2023
36546757Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.Nucleic Acids Res2023
35144655Somatic mutational profiles and germline polygenic risk scores in human cancer.Genome Med2022
35512711Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes.Am J Hum Genet2022
36171194Multi-context genetic modeling of transcriptional regulation resolves novel disease loci.Nat Commun2022
35697866Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms.Nat Genet2022
35804456DeCAF: a novel method to identify cell-type specific regulatory variants and their role in cancer risk.Genome Biol2022
35931050Multi-ancestry fine-mapping improves precision to identify causal genes in transcriptome-wide association studies.Am J Hum Genet2022
36263809The regulatory landscape of multiple brain regions in outbred heterogeneous stock rats.Nucleic Acids Res2022
35042540Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1.Genome Med2022
35144655Somatic mutational profiles and germline polygenic risk scores in human cancer.Genome Med2022
35804456DeCAF: a novel method to identify cell-type specific regulatory variants and their role in cancer risk.Genome Biol2022
35697866Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms.Nat Genet2022
35512711Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes.Am J Hum Genet2022
35931050Multi-ancestry fine-mapping improves precision to identify causal genes in transcriptome-wide association studies.Am J Hum Genet2022
36171194Multi-context genetic modeling of transcriptional regulation resolves novel disease loci.Nat Commun2022
36263809The regulatory landscape of multiple brain regions in outbred heterogeneous stock rats.Nucleic Acids Res2022
35042540Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1.Genome Med2022
34099491Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival.Cancer Res2021
33789101Trans-ethnic variation in germline variants of patients with renal cell carcinoma.Cell Rep2021
34099491Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival.Cancer Res2021
33831007Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improves the power of transcriptome-wide association studies.PLoS Genet2021
34822763H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.Am J Hum Genet2021
34820595Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.JCO Precis Oncol2021
34699744Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.Am J Hum Genet2021
34749793Constructing germline research cohorts from the discarded reads of clinical tumor sequences.Genome Med2021
33789101Trans-ethnic variation in germline variants of patients with renal cell carcinoma.Cell Rep2021
33831007Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improves the power of transcriptome-wide association studies.PLoS Genet2021
34822763H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.Am J Hum Genet2021
34820595Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.JCO Precis Oncol2021
34699744Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.Am J Hum Genet2021
34749793Constructing germline research cohorts from the discarded reads of clinical tumor sequences.Genome Med2021
31595288Annotations capturing cell type-specific TF binding explain a large fraction of disease heritability.Hum Mol Genet2020
31595288Annotations capturing cell type-specific TF binding explain a large fraction of disease heritability.Hum Mol Genet2020
32424349Quantifying genetic effects on disease mediated by assayed gene expression levels.Nat Genet2020
32130895Germline Features Associated with Immune Infiltration in Solid Tumors.Cell Rep2020
32004450Allele-Specific QTL Fine Mapping with PLASMA.Am J Hum Genet2020
32398369Secure large-scale genome-wide association studies using homomorphic encryption.Proc Natl Acad Sci U S A2020
32332753Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.Nat Commun2020
33257650Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations.Nat Commun2020
32693805Optimized homomorphic encryption solution for secure genome-wide association studies.BMC Med Genomics2020
32690948Prostate cancer reactivates developmental epigenomic programs during metastatic progression.Nat Genet2020
  • 1 - 50 of 150

Recommended Authors

Yosuke Tanigawa
USA Broad Institute of MIT and Harvard
Career Start Year 2018
Number of shared co-authors 6
Goo Jun
University of Texas Health Science Center at Houston
Career Start Year 2012
Number of shared co-authors 16
Xia Shen
Usher Institute, University of Edinburgh
Career Start Year 2011
Number of shared co-authors 15
Christopher DeBoever
Stanford University
Career Start Year 2010
Number of shared co-authors 3
Konrad J Karczewski
Broad Institute of MIT and Harvard
Career Start Year 2010
Number of shared co-authors 33
Eric R Gamazon
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 34
Hailiang Huang
Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 56
Yun Li
University of British Columbia
Career Start Year 2007
Number of shared co-authors 55
Chad D Huff
University of Texas M.D. Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 51
Tuuli Lappalainen
Columbia University
Career Start Year 2006
Number of shared co-authors 16
Gabriel E Hoffman
Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai
Career Start Year 2006
Number of shared co-authors 19
William S Bush
Cleveland Institute for Computational Biology, Case Western Reserve University
Career Start Year 2006
Number of shared co-authors 48
Benjamin F Voight
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 41
Tushar Bhangale
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 32
Stephen B Montgomery
Stanford University
Career Start Year 2003
Number of shared co-authors 29
Andrew D Skol
The University of Chicago
Career Start Year 2001
Number of shared co-authors 17
Andrew S Allen
Duke University School of Medicine
Career Start Year 2001
Number of shared co-authors 4
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 41
Kai Wang
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 32
Matthew Stephens
University of Chicago
Career Start Year 2000
Number of shared co-authors 17
Gon??alo R Abecasis
Regeneron Pharmaceuticals Inc.
Career Start Year 2000
Number of shared co-authors 92
Nicole Soranzo
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 56
Sarah E Hunt
European Bioinformatics Institute
Career Start Year 1997
Number of shared co-authors 42
Andrew P Morris
The University of Manchester
Career Start Year 1997
Number of shared co-authors 64
Jonathan Marchini
Regeneron Pharmaceuticals Inc
Career Start Year 1997
Number of shared co-authors 51
Devin Absher
Kaiser Permanente Research Bank
Career Start Year 1994
Number of shared co-authors 61
Christopher S Carlson
University of Washington
Career Start Year 1994
Number of shared co-authors 42
David A Hinds
23andMe Inc.
Career Start Year 1992
Number of shared co-authors 59
Albert V Smith
University of Michigan School of Public Health ann arbor
Career Start Year 1987
Number of shared co-authors 79
Kelly A Frazer
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 19

Collaborators

Bogdan Pasaniuc
David Geffen School of Medicine, University of California los angeles
Co-authored papers 24
Alkes L Price
Broad Institute of MIT and Harvard
Co-authored papers 22
Hilary K Finucane
Co-authored papers 14
Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 12
Itsik Pe'er
Columbia University
Co-authored papers 12
Noah Zaitlen
Co-authored papers 12
Benjamin M Neale
Massachusetts General Hospital
Co-authored papers 11
Mark J Daly
Massachusetts General Hospital
Co-authored papers 9
Nick Patterson
Harvard University
Co-authored papers 9
Steven Gazal
Co-authored papers 8
Peter Kraft
Harvard T. H. Chan School of Public Health
Co-authored papers 7
Mark M Pomerantz
Dana-Farber Cancer Institute
Co-authored papers 7
Soumya Raychaudhuri
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 6
Eimear E Kenny
Icahn School of Medicine at Mount Sinai, NY Institute for Genomic Health
Co-authored papers 6
Christopher A Haiman
University of Southern California
Co-authored papers 5
Patrick F Sullivan
University of North Carolina at Chapel Hill
Co-authored papers 5
Samuela Pollack
Harvard T.H. Chan School of Public Health
Co-authored papers 5
Connor Bell
Dana-Farber Cancer Institute
Co-authored papers 5
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 5
Xuanyao Liu
Co-authored papers 5
Eli A Stahl
Co-authored papers 5
Stephan Ripke
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
Wei Zheng
Co-authored papers 4
Sylvan C Baca
Co-authored papers 4
Steven A McCarroll
Co-authored papers 4
David Altshuler
Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Co-authored papers 4
Naomi R Wray
Institute of Molecular Bioscience, The University of Queensland
Co-authored papers 4
Peter K Gregersen
Co-authored papers 4
Edward O'Connor
Dana-Farber Cancer Institute
Co-authored papers 4
Shaun Purcell
Brigham and Women's Hospital
Co-authored papers 4
Release 1.2